The US Food and Drug Administration (FDA) has approved diabetes drug Liraglutide (Saxenda, Novo Nordisk) for the treatment of obesity.
Forfeiting our commons
The Lancet’s Series on Maternal and Child Undernutrition
President Obama's grand climate plan does not add up
Climate change can no longer be ignored
NGO demands withdrawal of Niyamgiri gram sabha notificatio